TY  - GEN
AU  - Neri,B
AU  - Doni,L
AU  - Gemelli,M T
AU  - Fulignati,C
AU  - Turrini,M
AU  - Di Cello,V
AU  - Dominici,A
AU  - Maleci,M
AU  - Mottola,A
AU  - Ponchietti,R
AU  - Raugei,A
AU  - Valsuani,G
AU  - Cini,G
TI  - Phase II trial of weekly intravenous gemcitabine administration with interferon and interleukin-2 immunotherapy for metastatic renal cell cancer
SN  - 0022-5347
PY  - 2002///0918
KW  - Aged
KW  - Antineoplastic Agents
KW  - administration & dosage
KW  - Antineoplastic Combined Chemotherapy Protocols
KW  - therapeutic use
KW  - Carcinoma, Renal Cell
KW  - drug therapy
KW  - Deoxycytidine
KW  - Female
KW  - Humans
KW  - Immunotherapy
KW  - Infusions, Intravenous
KW  - Injections, Intramuscular
KW  - Interferon-alpha
KW  - Interleukin-2
KW  - Kidney Neoplasms
KW  - pathology
KW  - Male
KW  - Middle Aged
KW  - Gemcitabine
N1  - Publication Type: Clinical Trial; Clinical Trial, Phase II; Journal Article; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1016/S0022-5347(05)64550-8
ER  -